Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · IEX Real-Time Price · USD
1.420
+0.020 (1.43%)
Mar 28, 2024, 9:30 AM EDT - Market open

Adial Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016
Cash & Equivalents
46.064.46.783.870.020.09
Short-Term Investments
0000000.04
Cash & Cash Equivalents
46.064.46.783.870.020.12
Cash Growth
-33.99%37.74%-35.06%75.16%21102.56%-85.18%-
Other Current Assets
0.780.40.730.90.820.010.02
Total Current Assets
4.786.465.147.674.690.030.14
Property, Plant & Equipment
00.300000
Goodwill and Intangibles
00.250.010.010.010.010.01
Other Long-Term Assets
0.950.460.350000
Total Long-Term Assets
0.951.010.360.010.010.010.01
Total Assets
5.737.475.497.684.70.030.15
Accounts Payable
0.280.290.650.190.10.340.02
Current Debt
00.050000.690.23
Other Current Liabilities
1.512.390.860.350.1600
Total Current Liabilities
1.792.721.510.540.261.030.26
Long-Term Debt
00.2100000
Other Long-Term Liabilities
0.671.0400000
Total Long-Term Liabilities
0.671.2400000
Total Liabilities
2.463.971.510.540.261.030.26
Total Debt
00.260000.690.23
Debt Growth
-----194.24%-
Retained Earnings
-63.67-50.94-31.52-20.63-12.04-0.4-9.94
Shareholders' Equity
3.283.513.997.144.44-1-0.1
Net Cash / Debt
45.814.46.783.87-0.67-0.11
Net Cash / Debt Growth
-31.07%31.90%-35.06%75.16%---
Net Cash Per Share
4.007.818.8317.2020.32-5.14-0.85
Working Capital
2.993.743.637.134.43-1-0.11
Book Value Per Share
3.274.728.0018.1223.33-7.64-0.79
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).